These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 37709999)
1. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Mitchell JM; Ot'alora G M; van der Kolk B; Shannon S; Bogenschutz M; Gelfand Y; Paleos C; Nicholas CR; Quevedo S; Balliett B; Hamilton S; Mithoefer M; Kleiman S; Parker-Guilbert K; Tzarfaty K; Harrison C; de Boer A; Doblin R; Yazar-Klosinski B; Nat Med; 2023 Oct; 29(10):2473-2480. PubMed ID: 37709999 [TBL] [Abstract][Full Text] [Related]
2. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Mitchell JM; Bogenschutz M; Lilienstein A; Harrison C; Kleiman S; Parker-Guilbert K; Ot'alora G M; Garas W; Paleos C; Gorman I; Nicholas C; Mithoefer M; Carlin S; Poulter B; Mithoefer A; Quevedo S; Wells G; Klaire SS; van der Kolk B; Tzarfaty K; Amiaz R; Worthy R; Shannon S; Woolley JD; Marta C; Gelfand Y; Hapke E; Amar S; Wallach Y; Brown R; Hamilton S; Wang JB; Coker A; Matthews R; de Boer A; Yazar-Klosinski B; Emerson A; Doblin R Nat Med; 2021 Jun; 27(6):1025-1033. PubMed ID: 33972795 [TBL] [Abstract][Full Text] [Related]
3. MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial. Ching TH; Williams MT; Wang JB; Jerome L; Yazar-Klosinski B; Emerson A; Doblin R J Psychopharmacol; 2022 Aug; 36(8):974-986. PubMed ID: 35727042 [TBL] [Abstract][Full Text] [Related]
4. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331 [TBL] [Abstract][Full Text] [Related]
5. MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study. Mitchell JM; Bogenschutz M; Lilienstein A; Harrison C; Kleiman S; Parker-Guilbert K; Ot'alora G M; Garas W; Paleos C; Gorman I; Nicholas C; Mithoefer M; Carlin S; Poulter B; Mithoefer A; Quevedo S; Wells G; Klaire SS; van der Kolk B; Tzarfaty K; Amiaz R; Worthy R; Shannon S; Woolley JD; Marta C; Gelfand Y; Hapke E; Amar S; Wallach Y; Brown R; Hamilton S; Wang JB; Coker A; Matthews R; de Boer A; Yazar-Klosinski B; Emerson A; Doblin R Focus (Am Psychiatr Publ); 2023 Jul; 21(3):315-328. PubMed ID: 37404971 [TBL] [Abstract][Full Text] [Related]
6. MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD. Brewerton TD; Wang JB; Lafrance A; Pamplin C; Mithoefer M; Yazar-Klosinki B; Emerson A; Doblin R J Psychiatr Res; 2022 May; 149():128-135. PubMed ID: 35272210 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials. Jerome L; Feduccia AA; Wang JB; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R Psychopharmacology (Berl); 2020 Aug; 237(8):2485-2497. PubMed ID: 32500209 [TBL] [Abstract][Full Text] [Related]
8. The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD. Nicholas CR; Wang JB; Coker A; Mitchell JM; Klaire SS; Yazar-Klosinski B; Emerson A; Brown RT; Doblin R Drug Alcohol Depend; 2022 Apr; 233():109356. PubMed ID: 35286849 [TBL] [Abstract][Full Text] [Related]
9. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Mithoefer MC; Feduccia AA; Jerome L; Mithoefer A; Wagner M; Walsh Z; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R Psychopharmacology (Berl); 2019 Sep; 236(9):2735-2745. PubMed ID: 31065731 [TBL] [Abstract][Full Text] [Related]
10. A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis. Illingworth BJ; Lewis DJ; Lambarth AT; Stocking K; Duffy JM; Jelen LA; Rucker JJ J Psychopharmacol; 2021 May; 35(5):501-511. PubMed ID: 33345689 [TBL] [Abstract][Full Text] [Related]
11. Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder. Ponte L; Jerome L; Hamilton S; Mithoefer MC; Yazar-Klosinski BB; Vermetten E; Feduccia AA J Trauma Stress; 2021 Aug; 34(4):851-863. PubMed ID: 34114250 [TBL] [Abstract][Full Text] [Related]
12. Effects of MDMA-assisted therapy for PTSD on self-experience. van der Kolk BA; Wang JB; Yehuda R; Bedrosian L; Coker AR; Harrison C; Mithoefer M; Yazar-Klosinki B; Emerson A; Doblin R PLoS One; 2024; 19(1):e0295926. PubMed ID: 38198456 [TBL] [Abstract][Full Text] [Related]
13. Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial. Marseille E; Mitchell JM; Kahn JG PLoS One; 2022; 17(2):e0263252. PubMed ID: 35213554 [TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials. Yang J; Wang N; Luo W; Gao J Psychiatry Res; 2024 Sep; 339():116043. PubMed ID: 38896930 [TBL] [Abstract][Full Text] [Related]
15. 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. Ot'alora G M; Grigsby J; Poulter B; Van Derveer JW; Giron SG; Jerome L; Feduccia AA; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R J Psychopharmacol; 2018 Dec; 32(12):1295-1307. PubMed ID: 30371148 [TBL] [Abstract][Full Text] [Related]
16. Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder. Zeifman RJ; Kettner H; Ross S; Weiss B; Mithoefer MC; Mithoefer AT; Wagner AC Eur J Psychotraumatol; 2024; 15(1):2297536. PubMed ID: 38174611 [TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). Oehen P; Traber R; Widmer V; Schnyder U J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis. Bahji A; Forsyth A; Groll D; Hawken ER Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109735. PubMed ID: 31437480 [TBL] [Abstract][Full Text] [Related]
19. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Danforth AL; Grob CS; Struble C; Feduccia AA; Walker N; Jerome L; Yazar-Klosinski B; Emerson A Psychopharmacology (Berl); 2018 Nov; 235(11):3137-3148. PubMed ID: 30196397 [TBL] [Abstract][Full Text] [Related]
20. MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis. Smith KW; Sicignano DJ; Hernandez AV; White CM J Clin Pharmacol; 2022 Apr; 62(4):463-471. PubMed ID: 34708874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]